Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

China Fines GSK $492M for Bribery

September 19, 2014 9:13 am | by Joe McDonald, AP Business Writer | News | Comments

Drug maker GlaxoSmithKline was fined $492 million on Friday for bribing doctors in China in the biggest such penalty ever imposed by a Chinese court. Read more...                         

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Soligenix Gets $24.7M for Development of Heat-Stable RiVax Vaccine

September 19, 2014 10:28 am | News | Comments

Soligenix Inc. announced that it has been awarded a contract valued at up to $24.7 million to advance the development of Soligenix’s thermostabilization technology, ThermoVax, combined with the company’s ricin toxin vaccine, RiVax. Read more...  

TOPICS:

Modified Antibiotic Can Vanquish Resistant Bacteria

September 19, 2014 10:23 am | News | Comments

Scientists have devised a new antibiotic based on vancomycin that is powerfully effective against vancomycin-resistant strains of MRSA and other disease-causing bacteria. Read more...                   

TOPICS:

A New Way to Prevent the Spread of Devastating Diseases

September 19, 2014 10:18 am | News | Comments

For decades, researchers have tried to develop broadly effective vaccines to prevent the spread of illnesses such as HIV, malaria, and tuberculosis. While limited progress has been made along these lines, there are still no licensed vaccinations available that can protect against these diseases. Now, researchers are approaching the problem in a different way. Read more...

TOPICS:
Advertisement

Pfizer Provides $2M to Support ‘Last-Mile’ Vaccine Coverage

September 19, 2014 10:04 am | News | Comments

The Pfizer Foundation announced $2 million in grant funding for pilot programs to improve immunization coverage in Africa. Grant recipients include UNICEF, Save the Children and International Rescue Committee. Read more...      

TOPICS:

New Approach to Arthritis Drug Delivery Could Help Avoid Side Effects

September 19, 2014 9:54 am | News | Comments

A new approach to arthritis treatment, which avoids unforeseen side effects by delivering drugs exclusively to affected inflamed joints, has been developed by researchers in London. Read more...                

TOPICS:

Gilead Cancer Drug Approved in Europe

September 19, 2014 9:22 am | News | Comments

Gilead Sciences Inc. announced that the European Commission has granted marketing authorization for Zydelig (idelalisib), a first-in-class oral treatment for chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). Read more...     

TOPICS:

Afamelanotide Holds Promise as Vitiligo Treatment

September 19, 2014 8:30 am | Videos | Comments

A treatment regimen is safe and effective for restoring skin pigmentation in vitiligo patients, according to a new study. Read more...                                 

TOPICS:

Why Live Vaccines May be Most Effective for Preventing Salmonella Infection

September 18, 2014 11:20 pm | News | Comments

Vaccines against Salmonella that use a live, but weakened, form of the bacteria are more effective than those that use only dead fragments because of the particular way in which they stimulate the immune system, according to new research. Read more...

TOPICS:
Advertisement

Vaccine Stops Catheter-Linked UTIs in Mice

September 18, 2014 4:13 pm | News | Comments

The most common type of hospital-associated infection may be preventable with a vaccine, new research in mice suggests. The experimental vaccine prevented urinary tract infections associated with catheters. Read more...          

TOPICS:

CDC Tells Healthy Adults Not to Forget Flu Vaccine

September 18, 2014 4:08 pm | by Lauran Neergaard, AP Medical Writer | News | Comments

It's time for flu vaccine again and while it's important for the whole family, this year health officials have some different advice for different ages. Read more...                         

TOPICS:

Lilly's Combo Treatment Improves OS in Gastric Cancer Patients

September 18, 2014 3:58 pm | News | Comments

Eli Lilly and Co. announced that results of the global Phase 3 trial of ramucirumab (Cyramza) in combination with paclitaxel in patients with advanced gastric (stomach) cancer or gastroesophageal junction (GEJ) adenocarcinoma were published in a sholarly journal. Read more...

TOPICS:

Otsuka, NuView Life Sciences Enter Global Licensing Agreement

September 18, 2014 3:50 pm | News | Comments

NuView Life Sciences announced entry into an exclusive global licensing and collaboration agreement with Otsuka Pharmaceutical Co. to further develop and commercialize NuView's investigative genomic-based diagnostic biomarker to detect cancers of the breast and prostate. Read more...

TOPICS:

FDA OKs Faster-Acting Label for ED Drug Stendra

September 18, 2014 3:43 pm | News | Comments

Federal regulators have approved a new label for Vivus' impotence drug, stating that it becomes effective in half the time that the previous label had stated. Read more...                       

TOPICS:

Texas A&M to Dedicate Key Element of Vaccine Center

September 18, 2014 3:28 pm | News | Comments

Texas Gov. Rick Perry will join other dignitaries in College Station at the dedication of what's described as a national pandemic influenza vaccine facility. Read more...                       

TOPICS:

Cubist Opening New International Headquarters in Zurich

September 18, 2014 9:21 am | News | Comments

Cubist Pharmaceuticals Inc. announced the official opening of its international headquarters in Zurich, Switzerland, reinforcing its commitment to global public health. Read more...                    

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading